Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study

Since definitive concurrent chemoradiotherapy (CRT) is standard therapy for inoperable esophageal squamous cell carcinoma (ESCC), early evaluation of treatment response is crucial for patients and would be useful in assessing response, especially in patients with severe side effects.

[1]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[2]  J. Thompson,et al.  The appearances of oesophageal carcinoma demonstrated on high-resolution, T2-weighted MRI, with histopathological correlation , 2007, European Radiology.

[3]  P. Mildenberger,et al.  Assessment of tumor microcirculation with dynamic contrast‐enhanced MRI in patients with esophageal cancer: Initial experience , 2008, Journal of magnetic resonance imaging : JMRI.

[4]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[5]  R. Boellaard,et al.  Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer , 2011, Annals of surgery.

[6]  Wolfgang Schröder,et al.  Predicting response to neoadjuvant therapy in esophageal cancer , 2011, Expert review of anticancer therapy.

[7]  D. Collins,et al.  Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. , 2011, AJR. American journal of roentgenology.

[8]  H. Matsubara,et al.  Apparent Diffusion Coefficient Values Measured by Diffusion-Weighted Imaging Predict Chemoradiotherapeutic Effect for Advanced Esophageal Cancer , 2011, Digestive Surgery.

[9]  A. Teoh,et al.  Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  M. Okada,et al.  Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasion. , 2013, Anticancer research.

[11]  D. Bihan Apparent Diffusion Coefficient and Beyond: What Diffusion MR Imaging Can Tell Us about Tissue Structure , 2013 .

[12]  Yingsong 櫻松 Lin 林,et al.  Epidemiology of Esophageal Cancer in Japan and China , 2013, Journal of epidemiology.

[13]  H. Matsubara,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting the Early Response to Chemoradiotherapy of Advanced Esophageal Squamous Cell Carcinoma , 2013, Digestive Surgery.

[14]  Joe Y. Chang,et al.  Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma , 2013, Radiation oncology.

[15]  Bram Stieltjes,et al.  Characterization and therapy monitoring of head and neck carcinomas using diffusion-imaging-based intravoxel incoherent motion parameters—preliminary results , 2013, Neuroradiology.

[16]  D. Le Bihan Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. , 2013, Radiology.

[17]  Chun Han,et al.  Investigation of Using Diffusion-Weighted Magnetic Resonance Imaging to Evaluate the Therapeutic Effect of Esophageal Carcinoma Treatment , 2014, Oncology Research and Treatment.

[18]  Namkug Kim,et al.  Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect of triggering methods on regional variability and measurement repeatability of quantitative parameters. , 2015, Radiology.

[19]  D. Shi,et al.  Preliminary study of IVIM-DWI and DCE-MRI in early diagnosis of esophageal cancer. , 2015, European review for medical and pharmacological sciences.

[20]  D. Kwong,et al.  Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[21]  D. Le Bihan,et al.  Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. , 2016, Radiology.

[22]  Jing Yan,et al.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging , 2016, BMC Cancer.

[23]  Chun Han,et al.  The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  M. Shinoda,et al.  Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer , 2016, Medicine.

[25]  Yu Xiao-ping,et al.  Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma , 2016, Journal of magnetic resonance imaging : JMRI.

[26]  L. Raffaele,et al.  Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy , 2016, European journal of radiology open.

[27]  L. Saal,et al.  Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer , 2016, BMC Cancer.

[28]  Xiaoyan Zhang,et al.  Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion‐weighted MRI in locally advanced rectal cancer: A prospective single‐center study , 2017, Journal of magnetic resonance imaging : JMRI.

[29]  Narinder Kumar,et al.  Worldwide incidence, mortality and time trends for cancer of the oesophagus , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[30]  M. Hiraoka,et al.  Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method , 2017, Journal of radiation research.